Search research articles
Contact Us
Filters
Showing results (811-820 of 932) with videos related to
Page
of 94
Sort By:
The Journal of Urology
|
September 16, 2020
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma
Xiao X Wei, Lillian Werner, Min Y Teo, et al.
Clinical Genitourinary Cancer
|
January 8, 2026
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, et al.
JAMA Network Open
|
June 10, 2022
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma
Vishal Navani, Matthew Ernst, J Connor Wells, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 6, 2023
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US
Emily M Rencsok, Natalie Slopen, Karen Autio, et al.
The American Journal of Geriatric Cardiology
|
June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly
Charles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
Clinical and Translational Radiation Oncology
|
May 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer
Anna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2026
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Susan Slovin, Xin Gao, Xiao X Wei, et al.
Cancer
|
February 11, 2026
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel
Rana R McKay, Benjamin L Maughan, Alicia K Morgans, et al.
Clinical Genitourinary Cancer
|
August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
Kevin Hakimi, Ava Saidian, Justine Panian, et al.
Prostate Cancer and Prostatic Diseases
|
July 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
Amanda Broderick, Elizabeth Pan, Jinju Li, et al.
Page
of 94
Search research articles
Search
Showing results (811-820 of 932) with videos related to
Sort By:
Page
of 94
The Journal of Urology
|
September 16, 2020
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma
Xiao X Wei, Lillian Werner, Min Y Teo, et al.
Clinical Genitourinary Cancer
|
January 8, 2026
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, et al.
JAMA Network Open
|
June 10, 2022
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma
Vishal Navani, Matthew Ernst, J Connor Wells, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 6, 2023
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US
Emily M Rencsok, Natalie Slopen, Karen Autio, et al.
The American Journal of Geriatric Cardiology
|
June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly
Charles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
Clinical and Translational Radiation Oncology
|
May 28, 2026
Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer
Anna M Dornisch, Mariluz Rojo Domingo, Roberta Vezza Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2026
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Susan Slovin, Xin Gao, Xiao X Wei, et al.
Cancer
|
February 11, 2026
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel
Rana R McKay, Benjamin L Maughan, Alicia K Morgans, et al.
Clinical Genitourinary Cancer
|
August 9, 2023
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
Kevin Hakimi, Ava Saidian, Justine Panian, et al.
Prostate Cancer and Prostatic Diseases
|
July 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
Amanda Broderick, Elizabeth Pan, Jinju Li, et al.
Page
of 94